We are live on ! Find out more
CC

ClearArc Capital Portfolio holdings

AUM $257M
1-Year Est. Return 33.81%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$434M
AUM Growth
+$29.2M
Cap. Flow
+$11.3M
Cap. Flow %
2.61%
Top 10 Hldgs %
16.68%
Holding
407
New
26
Increased
249
Reduced
113
Closed
16

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$2.08M
2
SVC
Service Properties Trust
SVC
+$1.9M
3
PPL
PPL Corp
PPL
+$1.79M
4
CPT icon
Camden Property Trust
CPT
+$1.59M
5
DRE
Duke Realty Corp.
DRE
+$1.53M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.55M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.1M
3
BP icon
BP
BP
+$798K
4
XRX icon
Xerox
XRX
+$774K
5
AZN icon
AstraZeneca
AZN
+$716K

Sector Composition

Rank Sector Weight
1 Financials 15.83%
2 Technology 14.13%
3 Healthcare 12.38%
4 Energy 11.6%
5 Industrials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRO
201
DELISTED
Marathon Oil Corporation
MRO
$544K 0.13%
13,615
-175
-1% -$6.46K
VLO icon
202
Valero Energy
VLO
$85.9B
$538K 0.12%
10,745
+196
+2% +$10.8K
AON icon
203
Aon
AON
$76B
$536K 0.12%
5,950
-12
-0.2% -$1.04K
TEL icon
204
TE Connectivity
TEL
$62.6B
$531K 0.12%
8,587
+145
+2% +$8.69K
OKE icon
205
Oneok
OKE
$54.5B
$527K 0.12%
7,741
+96
+1% +$6.07K
HES
206
DELISTED
Hess
HES
$526K 0.12%
5,323
-100
-2% -$9.02K
NFLX icon
207
Netflix
NFLX
$309B
$524K 0.12%
83,230
-70
-0.1% -$379
SYK icon
208
Stryker
SYK
$130B
$502K 0.12%
5,949
+128
+2% +$10.5K
CCI icon
209
Crown Castle
CCI
$32.2B
$499K 0.12%
6,718
+105
+2% +$7.87K
IVZ icon
210
Invesco
IVZ
$13.9B
$499K 0.12%
13,212
-13,277
-50% -$480K
PSA icon
211
Public Storage
PSA
$61.3B
$498K 0.11%
2,907
+30
+1% +$5.14K
CI icon
212
Cigna
CI
$74.6B
$496K 0.11%
5,394
-29
-0.5% -$2.49K
KMI icon
213
Kinder Morgan
KMI
$68.7B
$487K 0.11%
13,440
+179
+1% +$6.04K
NOC icon
214
Northrop Grumman
NOC
$81.2B
$481K 0.11%
4,020
-39
-1% -$4.71K
SRE icon
215
Sempra
SRE
$54.8B
$480K 0.11%
9,170
+174
+2% +$8.64K
SNDK
216
DELISTED
SANDISK CORP
SNDK
$475K 0.11%
4,548
+83
+2% +$7.54K
BEN icon
217
Franklin Resources
BEN
$17.2B
$468K 0.11%
8,083
+80
+1% +$4.38K
INTU icon
218
Intuit
INTU
$89B
$459K 0.11%
5,705
+85
+2% +$6.56K
BDX icon
219
Becton Dickinson
BDX
$48.2B
$455K 0.1%
3,945
+246
+7% +$27.9K
CB
220
DELISTED
CHUBB CORPORATION
CB
$455K 0.1%
4,933
+72
+1% +$6.62K
REGN icon
221
Regeneron Pharmaceuticals
REGN
$80.8B
$454K 0.1%
1,609
+54
+3% +$16K
MHFI
222
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$453K 0.1%
5,461
+103
+2% +$8.12K
VRTX icon
223
Vertex Pharmaceuticals
VRTX
$126B
$451K 0.1%
4,759
+95
+2% +$6.66K
CME icon
224
CME Group
CME
$94.8B
$449K 0.1%
6,335
+85
+1% +$5.98K
PCG icon
225
PG&E
PCG
$38.5B
$449K 0.1%
9,345
+285
+3% +$12.9K
7 8
9
10 11

Similar funds

BO
Bach Option Wanchai, Hong Kong $236M AUM 21.45% 1-Year Est. Return
GCA
Gideon Capital Advisors New York $291M AUM 28.95% 1-Year Est. Return
QCM
Quadrant Capital Management Fairfield, New Jersey $221M AUM 29.88% 1-Year Est. Return
AEPI
AH Equity Partners I Menlo Park, California $221M AUM
AC
Asturias Capital New York $220M AUM 39.56% 1-Year Est. Return
LA
Lau Associates Greenville, Delaware $201M AUM 26.29% 1-Year Est. Return
JFM
Jackson Financial Management Costa Mesa, California $194M AUM 21.54% 1-Year Est. Return
SHA
Shelter Harbor Advisors Weatogue, Connecticut $192M AUM 26.7% 1-Year Est. Return

ClearArc Capital's Q2 2014 Portfolio in Review

As of Q2 2014, ClearArc Capital held 407 positions worth $434M, up 7.2% from $405M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

ClearArc Capital's Q2 2014 filing shows 26 new, 249 increased, 113 reduced and 16 closed positions. Its largest new stake was Service Properties Trust: 12,988 shares worth $1.96M. The largest sale was Pfizer, an estimated $1.55M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • ClearArc Capital's largest Q2 2014 buy was Service Properties Trust: 12,988 shares worth $1.96M.
  • ClearArc Capital added most to SLB Ltd in Q2 2014, an estimated $2.08M increase.
  • ClearArc Capital's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.55M.
  • ClearArc Capital fully exited AstraZeneca in Q2 2014, selling an estimated $716K.
  • ClearArc Capital's ten largest holdings make up 17% of its $434M portfolio in Q2 2014.
  • ClearArc Capital opened 26 new positions and closed 16 in Q2 2014.
  • ClearArc Capital's portfolio value rose 7.2% quarter-over-quarter to $434M.

Based on ClearArc Capital's 13F filing for Q2 2014, filed 14 Aug 2014.